I was brought in to help the team at Cramer develop a web presence marketing Merck’s Encadix, a tablet form of the MS and leukemia-fighting drug Cladribine, that would allow MS sufferers to spread out doses and avoid painful injections. As of 2015, Encadix has not received FDA approval for sale in the US.